biomarkers

New research reported by Medical Xpress indicates that certain dietary patterns are associated with more favorable blood biomarkers linked to biological aging. The findings suggest that what people eat may influence measurable markers of the aging process, adding to growing interest in nutrition as a tool for healthy longevity.

A new report warns that a biomarker identified through artificial intelligence can appear accurate in its initial analysis yet still fail when put to its biggest test, typically validation in independent or clinical settings. The finding highlights a growing concern in medical research: AI-driven discoveries may reflect patterns in data rather than real, clinically useful signals, and researchers are being urged to apply stricter validation before trusting such results.

Researchers have highlighted three previously overlooked RNA molecules as potential new markers for colorectal cancer. The findings suggest these molecules could help detect the disease earlier and guide treatment choices, offering a possible addition to existing screening and diagnostic tools. Colorectal cancer remains one of the most common cancers worldwide, so any lead on earlier detection is drawing scientific and media attention.

MIT Technology Review reports on a new competition in which contestants race to lower their biological age, competing to demonstrate the greatest rejuvenation of their bodies. The contest highlights the growing interest in longevity science and aging biomarkers, drawing attention to how researchers and enthusiasts measure biological youth and whether such public competitions can meaningfully advance anti-aging science.

Researchers have announced CMAISE, a longitudinal multi-omics cohort study aimed at advancing precision medicine for sepsis, a life-threatening condition with limited treatment options. By tracking patients over time and integrating genomic, proteomic and other molecular data, the project seeks to identify biomarkers that could enable tailored therapies. The announcement has drawn attention from the medical research community interested in sepsis diagnostics.

Researchers are highlighting speech biomarkers as a potential tool for tracking brain aging. By analyzing vocal patterns, scientists hope to detect early signs of cognitive decline linked to conditions such as Alzheimer's disease. The approach could offer a non-invasive, low-cost way to monitor neurological health over time, though clinical validation remains ongoing.

Lori Brisbin, MS, MLS, discusses how liquid biopsies are changing precision medicine. The blood-based tests, which detect tumor DNA and other biomarkers without invasive procedures, are increasingly used to diagnose cancers, guide treatment choices, and monitor disease. Commentators in managed care circles are weighing the technology's clinical benefits against questions of cost, reimbursement, and broader adoption in routine practice.

Technology Networks has published an explainer on biomarkers and their role in precision medicine, outlining how biological markers are used to detect disease, predict progression and tailor treatments to individual patients. The piece walks through the main biomarker types and how they are shaping diagnostics and drug development.

Haga Bioscience and Imagenomix have announced a partnership to develop AI-based spatial biomarker analysis for cancer pathology. The collaboration aims to combine spatial biology techniques with artificial intelligence to improve how biomarkers are measured in tumor tissue, potentially supporting more precise cancer diagnosis and treatment decisions.